Introduction Glucagon-like peptide-1 (GLP-1) receptor agonists and sodium-glucose cotransporter-2 (SGLT-2) inhibitors are second to third line antihyperglycaemic drugs commonly prescribed for the treatment of type 2 diabetes.12 Individually, these drugs have been shown to reduce the risk of cardiorenal events and mortality in large cardiovascular outcome trials.3456789 However, the combined effect of these drug classes on these outcomes has not been extensively studied
: , DSIP
However, this can vary from person to person
Additionally, individuals ready to commit to a healthy lifestyle, are best suited for peptide use
DSIP Research Applications DSIP is studied in sleep physiology and chronobiology research, including delta-wave sleep architecture, hypothalamic-pituitary-axis interactions, cortisol and ACTH modulation, opioid receptor pathway research, and free-radical scavenging activity
The authors concluded that PTMs may occur at the level of this N-terminal region